Mass Tort Advertising Campaign
Chemical hair relaxers — both lye and no-lye formulations sold under brands including L'Oreal, Revlon, Soft Sheen-Carson, and Strength of Nature — are at the center of an active MDL alleging a link between long-term product use and uterine, endometrial, and ovarian cancers. The affected population is large, the injury is serious, and awareness among potential claimants remains uneven, which is precisely the environment where well-targeted paid social acquisition performs.
For plaintiff firms currently in the MDL or evaluating entry, the advertising opportunity is real: a defined product category, identifiable manufacturers, a specific injury set, and an audience that can be reached efficiently on Facebook and Instagram. MTAA builds and manages these campaigns end-to-end, from creative through intake handoff.
The hair relaxer litigation is consolidated as an MDL, with claims centered on lye and no-lye chemical relaxer products marketed and sold by major manufacturers — L'Oreal, Revlon, Soft Sheen-Carson, and Strength of Nature among them. Plaintiffs allege that repeated chemical exposure from these products is associated with uterine cancer, endometrial cancer, and ovarian cancer. The MDL structure means individual firms are actively building their dockets, and claimant acquisition is competitive but far from saturated.
Intake remains open, and the litigation is at a stage where firms that move now can accumulate case volume ahead of any significant docket-shaping developments. The injury profile — cancer diagnoses in women with documented relaxer use histories — creates a claimant pool that is motivated, identifiable, and responsive to direct-response social advertising when the messaging is handled with appropriate care and specificity.
The creative strategy for hair relaxer campaigns lives at the intersection of product familiarity and health consequence. These are household-name brands used routinely over years or decades — the advertising challenge is not explaining what a relaxer is, but connecting a trusted, normalized product to a serious diagnosis the claimant may never have associated with it. MTAA builds ad creative that surfaces that connection plainly, without sensationalism, in a way that prompts women who recognize their own history to take the next step. Video and static formats both perform in this vertical; the most effective units lead with the cancer diagnosis and work backward to product use, rather than leading with the legal claim.
Audience construction on Meta leverages demographic and behavioral signals aligned with the target profile — women in the relevant age bands, with content affinities that correlate with relaxer use history. Because the claimant population skews toward Black women who have used these products culturally and consistently over long periods, creative and copy must reflect that lived experience authentically, not generically. Intake qualification questions are built into the lead flow to surface use duration and diagnosis type before a lead ever reaches your intake team, so your staff is spending time on pre-screened prospects rather than raw volume.
Mass Tort Ad Agency runs Hair Relaxer / Uterine Cancer campaigns on the same transparent model as every tort: actual Meta ad spend at cost plus a flat 15% management fee, a one-time $1,000 setup fee per tort, and $100 per signed retainer for CloudIntake qualification. No per-case markups, no lead resale, and the firm owns its ad account, pixel, creative, and claimant data.
We build, run, and qualify Hair Relaxer / Uterine Cancer claimant-acquisition campaigns end to end. Book a call and we'll walk you through the creative, audience, and intake plan.
Book a strategy call